Companies / Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc.

Nasdaq: EIKNCIK 1861123MILLBRAE, CA

Ownership

54.1M shares outstanding · as of May 1, 2026
5.0%Insiders
Ownership
Insiders4.97%2,690,621
10%+ / strategic17.35%9,393,779
Institutions16.57%8,968,923
Public float61.11%33,085,305

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 31

View all →
Insider% of sharesShares
10.68%5,780,143
4.24%2,294,653
Wolfe JoshDirector · 10% owner
4.24%2,294,653
2.44%1,318,983
Perlmutter Roger MSee remarks · Director
0.53%284,857
0.21%111,111
Baynes Roy D.Chief Medical Officer
Bowie Alfred Lloyd Jr.Chief Financial Officer
Chen LeonDirector

Institutional holders 12

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 6, 2026The Column Group IV GP, LP
10% owner
BuyCommon Stock$25.87M+1.4M
+50.00%
4,312,139
7.96% of shares
high
Feb 6, 2026The Column Group IV GP, LP
10% owner
BuyCommon Stock$11.36M+631K
+91.66%
1,319,164
2.44% of shares
high
Feb 4, 2026Wolfe Josh
Director
BuyCommon Stock$2.50M+139K
138,888
0.26% of shares
high
Feb 4, 2026Wolfe Josh
Director
BuyCommon Stock$2.50M+139K
138,888
0.26% of shares
high
Feb 4, 2026Lux Venture Partners V, LLC
10% owner
BuyCommon Stock$2.50M+139K
138,888
0.26% of shares
high
Feb 4, 2026Lux Venture Partners V, LLC
10% owner
BuyCommon Stock$2.50M+139K
138,888
0.26% of shares
high
Feb 4, 2026Frazier Kenneth C
Director
BuyCommon Stock$2.00M+111K
111,111
0.21% of shares
high
Feb 4, 2026Foresite Capital Management IV, LLC
10% owner
BuyCommon Stock$1000.0K+56K
+4.40%
1,318,983
2.44% of shares
high

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Abu Dhabi Investment AuthorityPassive13G
Foresite Capital Fund IV, L.P.Passive13G
Perlmutter Roger MPassive13G

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
EIKN282564103